CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 28 enrolled
Drug / intervention
Proparacaine Ophthalmic +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00769392
NCT00769392N/ACompleted
CompareCT.gov

Pilot Study: A Randomized Trial Of Anesthetic Agents For Intravitreal Injection

Lahey Clinic·interventional·Posted Oct 9, 2008·Updated Mar 9, 2020

In Brief

A clinical study evaluating Proparacaine Ophthalmic, Tetracaine Ophthalmic, and 2 other interventions for Macular Degeneration. Completed, enrolled 28 participants across 3 sites.

Detailed Summary

This study is designed to compare four currently used types of anesthesia used prior to intravitreal injection in order to evaluate the most effective method of anesthesia in reducing pain and discomfort associated with intravitreal injections.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMacular Degeneration
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedOct 9, 2008
Enrollment StartSep 1, 2008
Primary CompletionAug 12, 2009
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 17.7 years ago

Interventions

Proparacaine Ophthalmicdrug

Drops of Proparacaine on the eye, administered as described in the package insert

Tetracaine Ophthalmicdrug

Drops of Tetracaine on the eye, administered as described in the package insert

Lidocaine 4%drug

A cotton sponge(pledget)soaked with Lidocaine 4% placed over the conjunctiva

Lidocaine 2% Injectable Solutiondrug

A subconjunctival injection of Lidocaine 2%